65872-43-7 Usage
Uses
Given the provided materials, the specific applications of 2-(2-Formamidothiazole-4-yl)-2-methoxyimino acetic acid are not explicitly detailed. However, based on its potential medicinal properties and its categorization as a chemical compound with a focus on pharmaceutical research, we can infer the following potential uses:
Used in Pharmaceutical Research:
2-(2-Formamidothiazole-4-yl)-2-methoxyimino acetic acid is used as a building block for the synthesis of new drugs, leveraging its unique structure and functional groups to explore its potential in creating novel therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2-(2-Formamidothiazole-4-yl)-2-methoxyimino acetic acid may serve as a key intermediate in the development of pharmaceutical compounds, potentially leading to the discovery of new treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 65872-43-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,8,7 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 65872-43:
(7*6)+(6*5)+(5*8)+(4*7)+(3*2)+(2*4)+(1*3)=157
157 % 10 = 7
So 65872-43-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H7N3O4S/c1-14-10-5(6(12)13)4-2-15-7(9-4)8-3-11/h2-3H,1H3,(H,12,13)(H,8,9,11)/b10-5-
65872-43-7Relevant articles and documents
Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
-
, (2008/06/13)
Provided are, among other things, compounds of formula I or IA, . Also provided are methods of treatment with such compounds.
Method for treating glaucoma IIB
-
, (2008/06/13)
Provided is a method of decreasing intraocular pressure or improving ocular accommodation in an animal, including a human, comprising administering an intraocular pressure decreasing amount or ocular accommodation improving amount of a compound of the formula I or IA, wherein J is oxygen, sulfur, or N—Rd.
3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
-
, (2008/06/13)
Preparation of pharmaceutical composition comprising, treatment of human and animal diseases with, and compound of 3,7-disubstituted-3-cepham-4-carboxylic acid.